**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****
+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 24549-06-2 |6-Ethyl-O-Toluidine | 98 | 246-309-6 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: XN
Risk Phrases: 20/21/22
**** SECTION 3 - HAZARDS IDENTIFICATION ****
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Potential Health Effects
Eye:
May cause eye irritation. May cause chemical conjunctivitis and
corneal damage.
Skin:
Absorption into the body may cause cyanosis (bluish discoloration of
skin due to deficient oxygenation of the blood). May cause irritation
and dermatitis. May cause cyanosis of the extremities.
Ingestion:
May cause gastrointestinal irritation with nausea, vomiting and
diarrhea. May cause liver and kidney damage. The toxicological
properties of this substance have not been fully investigated.
Methemoglobinemia is characterized by dizziness, drowsiness,
headache, shortness of breath, cyanosis (bluish discoloration of skin
due to deficient oxygenation of the blood), rapid heart rate and
chocolate-brown colored blood. Overexposure may cause
methemoglobinemia.
Inhalation:
May cause respiratory tract irritation. May cause liver and kidney
damage. The toxicological properties of this substance have not been
fully investigated. Aspiration may lead to pulmonary edema.
Methemoglobinemia is characterized by dizziness, drowsiness,
headache, shortness of breath, cyanosis (bluish discoloration of skin
due to deficient oxygenation of the blood), rapid heart rate and
chocolate-brown blood. Inhalation of aniline causes anoxia due to
the formation of methemoglobin. Inhalation at high concentrations
may cause CNS depression and asphixiation.
Chronic:
May cause liver and kidney damage. May cause methemoglobinemia,
which is characterized by chocolate-brown colored blood, headache,
weakness, dizziness, breath shortness, cyanosis (bluish skin due to
deficient oxygenation of blood), rapid heart rate, unconsciousness
and possible death. Effects may be delayed.
**** SECTION 4 - FIRST AID MEASURES ****
Eyes:
Flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15
minutes while removing contaminated clothing and shoes. Wash clothing
before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and
drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not
breathing, give artificial respiration. If breathing is difficult,
give oxygen. Get medical aid. Do NOT use mouth-to-mouth
resuscitation.
Notes to Physician:
For methemoglobinemia, administer oxygen alone or with Methylene
Blue depending on the methemoglobin concentration in the blood.
Antidote:
Methylene blue, alone or in combination with oxygen is indicated as
a treatment in nitrite induced methemoglobinemia.
**** SECTION 5 - FIRE FIGHTING MEASURES ****
General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Use water
spray to keep fire-exposed containers cool. Water may be ineffective.
Material is lighter than water and a fire may be spread by the use of
water. Combustible liquid. Vapors may be heavier than air. They can
spread along the ground and collect in low or confined areas.
Containers may explode when heated.
Extinguishing Media:
Use water spray to cool fire-exposed containers. Use agent most
appropriate to extinguish fire. Use water spray, dry chemical,
carbon dioxide, or appropriate foam.
**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****
General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth),
then place in suitable container. Avoid runoff into storm sewers and
ditches which lead to waterways. Clean up spills immediately,
observing precautions in the Protective Equipment section. Remove all
sources of ignition. Use a spark-proof tool. Provide ventilation.
**** SECTION 7 - HANDLING and STORAGE ****
Handling:
Wash thoroughly after handling. Use only in a well-ventilated area.
Avoid contact with eyes, skin, and clothing. Empty containers retain
product residue, (liquid and/or vapor), and can be dangerous. Keep
container tightly closed. Keep away from heat, sparks and flame.
Avoid ingestion and inhalation. Do not pressurize, cut, weld, braze,
solder, drill, grind, or expose empty containers to heat, sparks or
open flames.
Storage:
Keep away from heat, sparks, and flame. Keep away from sources of
ignition. Store in a tightly closed container. Store in a cool, dry,
well-ventilated area away from incompatible substances.
**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****
Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 24549-06-2:
Personal Protective Equipment
Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin
exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.
**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****
Physical State: Liquid
Color: clear yellow
Odor: None reported.
pH: Not available.
Vapor Pressure: 0.06 mmHg @ 20
Viscosity: Not available.
Boiling Point: 231 deg C @ 760.00mmHg
Freezing/Melting Point: -33 deg C
Autoignition Temperature: Not applicable.
Flash Point: 89 deg C ( 192.20 deg F)
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: .9680g/cm3
Molecular Formula: C9H13N
Molecular Weight: 135.21
**** SECTION 10 - STABILITY AND REACTIVITY ****
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, ignition sources, excess heat.
Incompatibilities with Other Materials:
Oxidizing agents
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, irritating and toxic fumes and
gases, carbon dioxide, nitrogen, ammonia.
Hazardous Polymerization: Has not been reported.
**** SECTION 11 - TOXICOLOGICAL INFORMATION ****
RTECS#:
CAS# 24549-06-2: BY5600000
LD50/LC50:
CAS# 24549-06-2: Inhalation, rat: LC50 = 2200 mg/m3/4H; Oral, mouse:
LD50 = 930 mg/kg; Oral, rabbit: LD50 = 700 mg/kg; Oral, rat: LD50 =
885 mg/kg.
Carcinogenicity:
6-Ethyl-O-Toluidine -
Not listed by ACGIH, IARC, or NTP.
Other:
See actual entry in RTECS for complete information.
**** SECTION 12 - ECOLOGICAL INFORMATION ****
**** SECTION 13 - DISPOSAL CONSIDERATIONS ****
Dispose of in a manner consistent with federal, state, and local regulations.
**** SECTION 14 - TRANSPORT INFORMATION ****
IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.
**** SECTION 15 - REGULATORY INFORMATION ****
European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
Safety Phrases:
S 23 Do not inhale gas/fumes/vapour/spray.
S 24/25 Avoid contact with skin and eyes.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 24549-06-2: 2
Canada
CAS# 24549-06-2 is listed on Canada's DSL List.
CAS# 24549-06-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 24549-06-2 is listed on the TSCA inventory.
**** SECTION 16 - ADDITIONAL INFORMATION ****
MSDS Creation Date: 9/02/1997 Revision #6 Date: 3/18/2003
The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
|
|
|
| ALL MSDS PAGES IN THIS GROUP
| | NAME | CAS |
|
Niobocene dichloride
| 12793-14-5 |
|
4,4-Diethoxy-2-butyn-1-al, 97+% (GC)
| 74149-25-0 |
|
Beta-(1,4)-2-Amino-2-Deoxy-D-Glucose
| 9012-76-4 |
|
9,10-Anthracenedicarbonitrile, 99% (UV-Vis)
| 1217-45-4 |
|
alpha-Hydroxyacetophenone, 97%
| 582-24-1 |
|
Cyclopentyl chloride, 99+%
| 930-28-9 |
|
5'-O-Dimethoxytrityl-N-Benzoyl-Desoxycyti-Dine
| 67219-55-0 |
|
4,4,4-Trifluoro-1-phenyl-1,3-butanedione
| 326-06-7 |
|
6-Ethyl-O-Toluidine, 98+%
| 24549-06-2 |
|
2-Phenylindolizine, 99+%
| 25379-20-8 |
|
2-Methyl-3-Buten-2-Ol, 97%
| 115-18-4 |
|
1,3,5-Triacetylbenzene, 98%
| 779-90-8 |
|
Propylamine Hydrochloride, 99+%
| 556-53-6 |
|
3,5-Dinitrosalicylic Acid, 98%
| 609-99-4 |
|
2-Methyl-3-Butyn-2-Ol, 98%
| 115-19-5 |
|
Coumarin 307, laser grade, 98% (uv-vis)
| 55804-70-1 |
|
Calcium Fluoride, 99.99%
| 7789-75-5 |
|
1,3-Dichloro-2-propanol, 99%
| 96-23-1 |
|
1,2:3,5-Di-O-Isopropylidene-Alpha-D-Xylofuranose, 98%
| 20881-04-3 |
|
3,5-Dimethoxybenzoyl chloride, ca. 92%, balance is corresponding acid
| 17213-57-9 |
|
(-)-alpha-Pinene, 98%
| 7785-26-4 |
|
2-Methyl-3-pentanol, 99+%
| 565-62-8 |
|
Mem Chloride, 94-98%(GC)
| 3970-21-6 |
|
Ethyl Crotonate, 96%
| 623-70-1 |
|
2,4-Dinitrophenol, moistened with up to 35% water
| 51-28-5 |
|
2-(Phenylthio)Ethanol, 99%
| 699-12-7 |
|
1-Anthraquinonesulfonic Acid Sodium Salt (Pract), Containing up to
| 128-56-3 |
|
4-(4-Biphenylyl)-2-Methylthiazole, 97%
| 24864-19-5 |
|
4,4'-Dithiodipyridine, 98%
| 2645-22-9 |
|
1-Pentanethiol, 98%
| 110-66-7 |
|
3-Methylsulphonylbenzoic Acid, 95+%
| 5345-27-7 |
|
Hexyl sodium sulfate, pract., 98%
| 2207-98-9 |
|
3-Benzyloxybenzaldehyde,98%
| 1700-37-4 |
|
(s)-3-Butene-1,2-diol, 99% (gc)
| 62214-39-5 |
|
N,N-Dibenzylhydroxylamine, 98%
| 621-07-8 |
|
5-Iodosalicylic acid, 97%
| 119-30-2 |
|
1-Adamantyl methyl ketone, 99%
| 1660-04-4 |
|
6-Bromo-2-Naphthol, 97%
| 15231-91-1 |
|
Furoin, 98%
| 552-86-3 |
|
Iminostilbene, 97%
| 256-96-2 |
|
(+/-)-Citronellic Acid
| 502-47-6 |
|
1-Ethylpyridinium Bromide, 98%
| 1906-79-2 |
|
5-Norbornene-2-carbonitrile, 98% mixture of endo and exo
| 95-11-4 |
|
Isosorbide-5-Mononitrate, CHR
| 16051-77-7 |
|
2,2,4,5,5-Pentamethyl-3-Imidazoline-3-Oxide-1-Oxyl, Free Radical
| 18796-04-8 |
|
Undecylenic aldehyde, 97%
| 112-45-8 |
|
Lumazine, 98%
| 487-21-8 |
|
3-Fluorobenzoic Acid, 99%
| 455-38-9 |
|
2-(Bromomethyl)-Naphthalene, 96%
| 939-26-4 |
|
2,4-Dihydroxy-5,6-Dimethylpyrimidine 97%
| 26305-13-5 |
|
|